No Data
No Data
Express News | Verona Pharma PLC : Canaccord Genuity Raises Target Price to $106 From $72
Earnings Call Summary | Verona Pharma(VRNA.US) Q1 2025 Earnings Conference
Verona Pharma Sees Ohtuvayre Sales Doubling in Q1 2025, Projects Expanded Sales Team by Q3
Truist Securities Adjusts Verona Pharma Price Target to $100 From $76, Maintains Buy Rating
European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading
Economic Data in Focus as US Equity Futures Point to Mixed Start for Wall Street